Previous 10 | Next 10 |
ESMO Presentations of Libtayo® (cemiplimab), Fianlimab and Novel Bispecific Antibodies Showcase Expanding Potential of Regeneron's Oncology Pipeline in Multiple Cancers PR Newswire First-in-class Phase 1 data for two investigational bispecifics in advanced ovarian...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood is well-known in the investment world as the face of ARK Invest, the firm she founded in 2014. ARK itself stands for Active Research Knowledge. She became something of a cult figure during the speculative t...
Announcing the publication of the first guidelines on treatments for Ebola on Friday, the World Health Organization said that it recommends monoclonal antibodies Inmazeb and Ebanga developed by Regeneron ( NASDAQ: REGN ) and Ridgeback Bio for the viral disease, respectively. ...
The Director of the Centers for Disease Control and Prevention (CDC), Rochelle Walensky, announced plans to overhaul the agency on Wednesday after multiple errors in the COVID response battered its reputation. In an email sent to CDC staff, Dr. Walensky said reforms would include re...
As the U.S. prepares to transition from the acute phase of the pandemic, the Biden administration will stop purchases of COVID-19 vaccines, treatments, and tests as early as this fall, the White House COVID response coordinator Ashish Jha said. "My hope is that in 2023, you're going...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: China The Outlier
A historic piece of legislation that is set to become low this week, empowering Medicare to negotiate prescription drug prices, among its other measures, is unlikely to cause a significant impact on the pharma industry, Bank of America and UBS argue. On Friday, the House of Represen...
AbbVie ( NYSE: ABBV ), Roche ( OTCQX:RHHBY ), and Regeneron Pharmaceuticals ( NASDAQ: REGN ), which market and/or are developing new age-related macular degeneration ("AMD") treatments, will be buoyed by rising cases of the eye condition. A recent report fr...
The shares of Unity Biotechnology ( NASDAQ: UBX ) jumped ~93% in the pre-market Friday after the clinical-stage biotech said that its lead product candidate UBX1325 demonstrated a statistically significant treatment effect in patients with diabetic macular edema (DME) in a...
The Centers for Disease Control and Prevention (CDC) on Thursday revised recommendations for unvaccinated people easing the guidance on isolation following exposure to the virus. Per the latest advice, the CDC no longer recommends unvaccinated people to quarantine after exposure, ...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...